Avion Wealth’s Charles River Laboratories CRL Stock Holding History

Avion Wealth’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	4	–	–	﹤0.01%	1485
2026 Q1	$0	Sell	4 -3	-43%	-$556	﹤0.01%	1307
2025 Q4	$1K	Buy	7 +3	+75%	+$544	﹤0.01%	995
2025 Q3	$0	Buy	+4	New	+$635	﹤0.01%	1260
2025 Q2	–	Sell	-9	Closed	-$1K	–	1249
2025 Q1	$1K	Hold	9	–	–	﹤0.01%	835
2024 Q4	$1K	Buy	9 +3	+50%	+$578	﹤0.01%	832
2024 Q3	$1K	Hold	6	–	–	﹤0.01%	783
2024 Q2	$1K	Hold	6	–	–	﹤0.01%	707
2024 Q1	$2K	Hold	6	–	–	﹤0.01%	655
2023 Q4	$1K	Buy	6 +3	+100%	+$590	﹤0.01%	740
2023 Q3	$0	Sell	3 -2	-40%	-$411	﹤0.01%	860
2023 Q2	$1K	Buy	5 +2	+67%	+$398	﹤0.01%	542
2023 Q1	$0	Hold	3	–	–	﹤0.01%	573
2022 Q4	$0	Hold	3	–	–	﹤0.01%	474
2022 Q3	$1K	Hold	3	–	–	﹤0.01%	429
2022 Q2	$1K	Buy	+3	New	+$733	﹤0.01%	428

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Avion Wealth's CRL Position: Q2 2026 in Review

Avion Wealth held its Charles River Laboratories (CRL) position steady in Q2 2026 at 4 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1485.

Avion Wealth first reported a position in CRL in Q2 2022 and has held it in 16 quarters since. The position peaked at $2K in Q1 2024. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Avion Wealth held 4 shares of Charles River Laboratories worth $0 as of Q2 2026.
Avion Wealth left its Charles River Laboratories share count unchanged in Q2 2026.
Charles River Laboratories made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1485 holding.
Avion Wealth first reported a position in Charles River Laboratories in Q2 2022 and has held it in 16 quarters since.
Avion Wealth's Charles River Laboratories position peaked at $2K in Q1 2024.
565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.